ArticleCell reports. Medicine2025

Recreating pathophysiology of CLN2 disease and demonstrating reversion by TPP1 gene therapy in hiPSC-derived retinal organoids and retina-on-chip.

Serena Corti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.